Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.

Antimicrobial agents and chemotherapy - 1 Aug 2001

Ackermann G, Tang Y J, Kueper R, Heisig P, Rodloff A C, Silva J, Cohen S H

Abstract excerpt

Clostridium difficile is the etiological agent of antibiotic-associated colitis and the most common cause of hospital-acquired infectious diarrhea. Fluoroquinolones such as ciprofloxacin are associated with lower risks of C. difficile-associated diarrhea. In this study, we have analyzed 72 C. dif...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aza Compounds
Share to Clostridioides difficile
Share to DNA Gyrase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Topoisomerases, Type II

Share to Enterotoxins

Share to Fluoroquinolones

Share to Moxifloxacin

Share to Quinolines

Source

Open in PubMed Open full text

Identifiers

PMID: 11451695
DOI: 10.1128/AAC.45.8.2348-2353.2001
PMCID: PMC90652

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11451695-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA.PMID 11451695Read ↗

Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.Semantic proximity Read ↗

Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.Semantic proximity Read ↗

Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.Semantic proximity Read ↗

Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficileSemantic proximity Read ↗

High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.Semantic proximity Read ↗

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.Semantic proximity Read ↗

Molecular analysis of fluoroquinolone-resistance in Escherichia coli on the aspect of gyrase and multiple antibiotic resistance (mar) genes.Semantic proximity Read ↗

Characterizations of Clinical Isolates of Clostridium difficile by Toxin Genotypes and by Susceptibility to 12 Antimicrobial Agents, Including Fidaxomicin (OPT-80) and Rifaximin: a Multicenter Study in TaiwanSemantic proximity Read ↗

Clostridium perfringens Type A Isolates of Animal Origin with Decreased Susceptibility to Metronidazole Show Extensive Genetic Diversity.Semantic proximity Read ↗

Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure.Semantic proximity Read ↗

Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.Semantic proximity Read ↗

Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.